Abstract | OBJECTIVE:
Peptide YY (PYY3-36) and pancreatic polypeptide (PP) potently inhibit food intake in rodents and humans, however, it is unclear whether they have any synergistic/additive interaction in decreasing food intake. DESIGN AND METHODS: Fasted WT, Y2(-) (/) (-) , Y4(-) (/) (-) , or Y2Y4(-) (/) (-) mice were i.p. administrated with saline, PYY3-36, and/or PP. RESULTS: Combined injection of PYY3-36 and PP reduces food intake in an additive manner was demonstrated in this study. This effect is mediated via Y2 and Y4 receptors, respectively. It was demonstrated that PYY3-36 and PP activate distinct neuronal pathways in the hypothalamus, as demonstrated by immunostaining for c-fos, which shows distinct patterns in response to either hormone. After PYY3-36 injection, neurons in the dorsal aspect of the arcuate nucleus ( Arc), paraventricular nucleus, and dorso-medial nucleus of the hypothalamus ( DMH) are activated with minimal responses seen in the ventro-medial nucleus of the hypothalamus (VMH) and lateral hypothalamic area (LHA) of WT mice. These effects are absent in Y2(-) (/) (-) mice. PP activates preferably the lateral aspect of the Arc, the DMH, VMH, and LHA in a Y4 receptor-dependent manner. Importantly, the expression pattern of c-fos immunoreactive neurons induced by combined treatment appears to be the sum of the effects of single treatments rather than a result of synergistic interaction. CONCLUSIONS: These findings demonstrate that PYY3-36 and PP activate distinct pathways in the hypothalamus to reduce food intake in an additive manner.
|
Authors | Yan-Chuan Shi, Zhou Lin, Jackie Lau, Hui Zhang, Miyuki Yagi, Isabella Kanzler, Amanda Sainsbury, Herbert Herzog, Shu Lin |
Journal | Obesity (Silver Spring, Md.)
(Obesity (Silver Spring))
Vol. 21
Issue 12
Pg. E669-78
(Dec 2013)
ISSN: 1930-739X [Electronic] United States |
PMID | 23804428
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 The Obesity Society. |
Chemical References |
- Peptide Fragments
- Proto-Oncogene Proteins c-fos
- Receptors, Neuropeptide Y
- neuropeptide Y2 receptor
- neuropeptide Y4 receptor
- Peptide YY
- peptide YY (3-36)
- Pancreatic Polypeptide
|
Topics |
- Animals
- Arcuate Nucleus of Hypothalamus
(drug effects, metabolism)
- Body Weight
(drug effects)
- Eating
(drug effects)
- Fasting
- Immunohistochemistry
- MAP Kinase Signaling System
(genetics)
- Male
- Mice
- Mice, Knockout
- Neurons
(drug effects, metabolism)
- Pancreatic Polypeptide
(administration & dosage)
- Paraventricular Hypothalamic Nucleus
(drug effects, metabolism)
- Peptide Fragments
(administration & dosage)
- Peptide YY
(administration & dosage)
- Proto-Oncogene Proteins c-fos
(genetics, metabolism)
- Receptors, Neuropeptide Y
(genetics, metabolism)
|